Evidence map›Paper›PMID 11384975›Full record

ArticleThe Journal of biological chemistry2001

Myosin ii light chain phosphorylation regulates membrane localization and apoptotic signaling of tumor necrosis factor receptor-1.

Y Jin, S J Atkinson, J A Marrs, P J Gallagher

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Involvement of the Actin Machinery in Programmed Cell Death.Frontiers in cell and developmental biology · 2020
    Review
  4. Article
  5. Gene silencing NMII promotes axonal regeneration against contusive spinal cord injury in rats.International journal of clinical and experimental pathology · 2017
    Article
  6. Article
  7. Article
  8. Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression.Molecular therapy : the journal of the American Society of Gene Therapy · 2013
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Y JinDepartment of Cellular and Integrative Physiology and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
S J Atkinson
J A Marrs
P J Gallagher
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · US

Funding

Regulation of Apoptosis by DAPKR01HL054118 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI GALLAGHER, PATRICIA J · 1997 to 2006
$1.6M
NHLBI NIH HHS HL54118NHLBI NIH HHS R01 HL054118
6 · The paper itself

Abstract

Activation of myosin II by myosin light chain kinase (MLCK) produces the force for many cellular processes including muscle contraction, mitosis, migration, and other cellular shape changes. The results of this study show that inhibition or potentiation of myosin II activation via over-expression of a dominant negative or wild type MLCK can delay or accelerate tumor necrosis factor-alpha (TNF)-induced apoptotic cell death in cells. Changes in the activation of caspase-8 that parallel changes in regulatory light chain phosphorylation levels reveal that myosin II motor activities regulate TNF receptor-1 (TNFR-1) signaling at an early step in the TNF death signaling pathway. Treatment of cells with either ionomycin or endotoxin (lipopolysaccharide) leads to activation of myosin II and increased translocation of TNFR-1 to the plasma membrane independent of TNF signaling. The results of these studies establish a new role for myosin II motor activity in regulating TNFR-1-mediated apoptosis through the translocation of TNFR-1 to or within the plasma membrane.

Indexed as

ApoptosisArabidopsis ProteinsAnimalsAntigens, CDBiotinBlotting, WesternCaspase 8Caspase 9CaspasesCell DeathCell LineCell MembraneDogsEndotoxinsFatty Acid DesaturasesGenes, DominantAntigens, CDArabidopsis ProteinsBiotinCASP8 protein, humanCasp8 protein, mouseCASP9 protein, humanCasp9 protein, mouseCaspase 8Caspase 9CaspasesEndotoxinsFad7 protein, ArabidopsisFatty Acid DesaturasesIonomycinIonophoresLipopolysaccharidesMyosin Light ChainsMyosinsReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alpha

Identifiers

PMID11384975
PMCPMC2823800
OpenAlexW1983640053

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.